| Feature | ERO1B summary | Evidence |
|---|---|---|
| Verified identity | Human **ERO1B** encodes **ERO1-like protein beta / endoplasmic reticulum oxidoreductase 1 beta**, an ERO1-family sulfhydryl oxidase distinct from ERO1A but closely related to it. | (pqac-00000001, pqac-00000002, pqac-00000003) |
| Enzymatic class and cofactor | ERO1-family proteins are **FAD-containing protein disulfide oxidases** that drive oxidative protein folding in the ER. ERO1B is annotated as **EC 1.8.3.2** and is inferred to use the same core catalytic chemistry as mammalian ERO1A. | (pqac-00000001, pqac-00000003, pqac-00000007) |
| Reaction catalyzed | ERO1 proteins transfer oxidizing equivalents from the enzyme to **PDI**, while ultimately transferring electrons to **molecular oxygen**, which is reduced to **H2O2**. Net effect: regeneration of oxidized PDI for disulfide-bond formation in secretory proteins, coupled to peroxide production. | (pqac-00000003, pqac-00000007, pqac-00000009) |
| Primary substrate specificity | The best-supported direct substrate is **protein disulfide isomerase (PDI/PDIA1)** and related PDI-family oxidoreductases rather than mature secretory proteins directly. Secretory and membrane proteins are the downstream client substrates oxidized indirectly through the ERO1–PDI relay. | (pqac-00000008, pqac-00000009, pqac-00000012, pqac-00000013) |
| Biochemical role in oxidative folding | ERO1B functions in the **ER oxidative folding relay**, restoring oxidized PDI so PDI can introduce and rearrange disulfide bonds in nascent secretory-pathway proteins. This places ERO1B in the core machinery for ER proteostasis. | (pqac-00000003, pqac-00000006, pqac-00000007, pqac-00000009) |
| Subcellular localization | ERO1-family proteins are **ER-localized/ER-resident** oxidoreductases acting in the **ER lumen** on the folding of secretory and membrane proteins. For ERO1B, this localization is consistent with its signal peptide and role in ER oxidative folding. | (pqac-00000001, pqac-00000003, pqac-00000007, pqac-00000010) |
| Regulatory mechanisms | Mammalian ERO1 activity is controlled by **intramolecular regulatory disulfides** that switch the enzyme between more active and less active states depending on ER redox conditions. **PDI both serves as substrate and helps regulate ERO1 activity**, creating feedback control that limits hyperoxidation. | (pqac-00000007, pqac-00000011, pqac-00000012) |
| Coupling to ROS/redox homeostasis | Because oxygen is the terminal electron acceptor, ERO1 activity generates **stoichiometric H2O2**, linking disulfide production to ER redox tone and oxidative stress signaling. ERO1 therefore contributes both to protein folding and to ER ROS burden. | (pqac-00000003, pqac-00000007, pqac-00000010, pqac-00000014) |
| Relationship to unfolded protein response (UPR) | ERO1-family activity is integrated with **ER stress responses/UPR**: oxidative folding capacity must match client-protein load, and excessive non-native protein load can inhibit the ERO1–PDI relay. ERO1 expression/activity is therefore part of adaptive ER proteostasis control. | (pqac-00000007, pqac-00000010, pqac-00000011) |
| Biological pathways | Key pathways include **oxidative protein folding**, **ER proteostasis**, **protein secretion**, **disulfide-bond formation**, **ER stress/UPR**, and **redox homeostasis**. | (pqac-00000003, pqac-00000006, pqac-00000009, pqac-00000010) |
| Relationship to ERO1A | ERO1B is the **paralogue** of ERO1A; the two mammalian proteins share substantial sequence identity and **overlapping function**. ERO1A is broadly expressed, whereas ERO1B is more enriched in specialized secretory settings. | (pqac-00000002, pqac-00000012) |
| Tissue-expression pattern | Available evidence indicates **ERO1A is ubiquitous**, whereas **ERO1B is enriched in secretory tissues**, especially the **pancreas/islet beta-cell context**. Recent proteomic studies detected ERO1B in pancreatic-islet datasets and linked it to insulin-secretory biology. | (pqac-00000000, pqac-00000002) |
| Physiological roles | ERO1B is most plausibly specialized for **high secretory demand**, supporting maturation of disulfide-rich proteins in endocrine/exocrine cells. Human and mouse studies associate ERO1B with **insulin biogenesis/islet function** and with broader secretory proteostasis. | (pqac-00000000, pqac-00000002) |
| Real-world/clinical associations | Recent human proteogenomic work associated circulating **ERO1B** measurements with **FEV1/lung function** and supported a potentially causal relationship in Mendelian-randomization analyses, though this does not yet define mechanism. | (pqac-00000000) |
| Functional redundancy with other oxidases | In mammals, ERO1 loss is **not absolutely essential** because alternative ER oxidizing systems can compensate, notably **PRDX4** and **GPX7/GPX8**. Combined ERO1A/ERO1B loss causes delayed disulfide formation but relatively mild organismal phenotypes compared with yeast ERO1 deficiency. | (pqac-00000001, pqac-00000002, pqac-00000003, pqac-00000014) |
| Evidence strength/limitations | Direct mechanistic literature on **human ERO1B specifically** is limited compared with ERO1A; many functional inferences rely on conserved ERO1-family biochemistry plus expression/physiology studies showing ERO1B enrichment in secretory tissues. | (pqac-00000001, pqac-00000003, pqac-00000007) |


*Table: This table consolidates the key functional characteristics of human ERO1B, including its enzymatic role, localization, regulation, pathway context, tissue expression, and redundancy with related oxidases. It is useful as a compact evidence-backed reference for gene functional annotation.*